CAS 3030-06-6: 1-Acetyl-5-bromo-4-chloro-1H-indol-3-yl acetate

5-Bromo-4-chloroindolyl-1,3-diacetate

Stability Moisture, Temperature, Light sensitive Applications 5-Bromo-4-chloro-3-indolyl-1,3-diacetate (cas# 3030-06-6) is a compound useful in organic synthesis.

5-Bromo-4-chloroindolyl 1,3-diacetate (5BCDA) is a clinical response predictor of postoperative radiotherapy. It is an acr20 response predictor for the diagnosis of chronic hepatitis C and the disease activity index in women with genital herpes. 5BCDA has been found to be effective in reducing levels of IL-17a and IL-17f, which are cytokines that are important for immune responses. 5BCDA has also been shown to be effective in treating infectious diseases such as malaria and tuberculosis.

5-Bromo-4-chloro-3-indoxyl-1,3-diacetate (BCID) is a potent and selective inhibitor of the tyrosine kinase enzyme. BCID has been shown to inhibit the growth of various cell cultures in vitro including murine and human cells. BCID has been shown to be an effective inhibitor of TNF-α production in murine models for asthma and allergic rhinitis. The drug has also been shown to reversibly inhibit the activity of the enzyme without affecting its ability to bind substrate or to regenerate active enzyme form inactive enzyme, indicating that it does not act as a suicide inhibitor.